| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1212/WNL.48.5_SUPPL_7.27S |
| P698 | PubMed publication ID | 9153164 |
| P2093 | author name string | Henderson VW | |
| P433 | issue | 5 Suppl 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| estrogen | Q277954 | ||
| P304 | page(s) | S27-35 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | The epidemiology of estrogen replacement therapy and Alzheimer's disease | |
| P478 | volume | 48 |
| Q36663043 | Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit? |
| Q77444521 | Allosteric modulation of neuronal nicotinic acetylcholine receptors |
| Q44311426 | Alterations of rCBF and mitochondrial dysfunction in major depressive disorder: a case report |
| Q43558020 | Altered apolipoprotein D expression in the brain of patients with Alzheimer disease |
| Q77787274 | Alzheimer's disease |
| Q33576938 | Androgen receptor gene and sex-specific Alzheimer's disease |
| Q22306052 | Androgens, Aging, and Alzheimer's Disease |
| Q35053241 | Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease. |
| Q44371288 | Basis of progesterone protection in spinal cord neurodegeneration |
| Q34244907 | Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model |
| Q44406385 | Can testosterone replacement decrease the memory problem of old age? |
| Q34037204 | Causes of Alzheimer's disease |
| Q28508461 | Chronic estrogen deficiency leads to molecular aberrations related to neurodegenerative changes in follitropin receptor knockout female mice |
| Q36919235 | Cognitive decline and dementia in the oldest-old |
| Q43873811 | Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17beta-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum |
| Q34777681 | Dementia epidemiology |
| Q48164930 | Different changes in concentrations of monoamines and their metabolites and amino acids in various brain regions by the herbal medicine/Toki-Shakuyaku-San between female and male senescence-accelerated mice (SAMP8). |
| Q44624452 | Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice |
| Q33680857 | Effects of estrogen in the CNS. |
| Q42528508 | Effects of estrogens on choline-acetyltransferase immunoreactivity and GAP-43 mRNA in the forebrain of young and aging male rats |
| Q44306076 | Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia |
| Q52036038 | Elderly care. Shifting thinking about memory impairment. |
| Q34079609 | Epidemiology of dementia: concepts and overview |
| Q24795759 | Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death |
| Q37085132 | Estradiol and neurodegenerative oxidative stress |
| Q40002859 | Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A. |
| Q48493353 | Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. |
| Q34037103 | Estradiol protects against ischemic brain injury in middle-aged rats |
| Q35235007 | Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol |
| Q46548523 | Estrogen replacement therapy in breast cancer survivors |
| Q35113338 | Estrogen-induced cell signalling in a cellular model of Alzheimer’s disease |
| Q34523361 | Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. |
| Q34132702 | Estrogens, brain and behavior: studies in fundamental neurobiology and observations related to women's health |
| Q43506804 | Evidence for novel estrogen binding sites in the rat hippocampus |
| Q34066971 | Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s |
| Q41729907 | Experimental and clinical methods in the development of anti-Alzheimer drugs |
| Q48466807 | Expression of estrogen receptor alpha and beta transcripts in female monkey hippocampus and hypothalamus |
| Q53289379 | Factors influencing survival among patients with vascular dementia and Alzheimer's disease. |
| Q35141447 | Functional aspects of estrogen neuroprotection |
| Q51719057 | Gender-specificities in Alzheimer's disease and mild cognitive impairment. |
| Q48230972 | Granule cells in aging rats are sexually dimorphic in their response to estradiol |
| Q35156240 | Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. |
| Q34491410 | Hormone replacement therapy at the threshold of 21st century |
| Q36475295 | Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. |
| Q33833550 | Hormones and cognition: current concepts and issues in neuropsychology |
| Q36050862 | How reward and emotional stimuli induce different reactions across the menstrual cycle. |
| Q43828091 | Implicit memory varies across the menstrual cycle: estrogen effects in young women |
| Q35679176 | In vivo effects of estrogen on human brain. |
| Q40404638 | Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action |
| Q42452756 | Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement |
| Q35041554 | Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats |
| Q36120187 | Marked gender differences in progression of mild cognitive impairment over 8 years |
| Q48832069 | Memory after menopause: preliminary considerations of hormone influence on cognitive functioning |
| Q34673883 | Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury |
| Q36237862 | Neuroendocrinology of female aging |
| Q34609480 | Ovarian hormones, aging and stress on hippocampal synaptic plasticity |
| Q48108819 | Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex. |
| Q36473816 | Polycystic ovary syndrome: etiology and pathogenesis |
| Q38188666 | Prevalence of glaucoma in hospitalized older adults with Alzheimer's disease |
| Q30437323 | Progesterone-estrogen interactions in synaptic plasticity and neuroprotection |
| Q24810197 | Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism |
| Q53751437 | Raloxifene: magic bullet for heart and bone? |
| Q37753303 | Regulation of hippocampal synaptic plasticity by estrogen and progesterone |
| Q41676936 | Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures |
| Q48966465 | Sex is all in the brain: report of a Novartis Foundation Symposium on the Neuronal and Cognitive Effects of Oestrogens, London, UK, 7-9 September 1999. |
| Q34039304 | Strategies to delay the onset of Alzheimer's disease. |
| Q35641917 | Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. |
| Q40839439 | Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway |
| Q37149774 | The medical management of menopause: to treat or not to treat? |
| Q24683330 | The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties |
| Q53224603 | The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist. |
| Q33757760 | The role of SERMs in the management of postmenopausal osteoporosis |
| Q34194402 | The role of estrogen replacement therapy in Alzheimer's disease |
| Q35118037 | The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus |
| Q60368820 | Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease |
| Q40474001 | Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants. |
| Q30386999 | Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearing. |
| Q92310720 | Young Coconut Juice Reduces Some Histopathological Changes Associated with Alzheimer's Disease through the Modulation of Estrogen Receptors in Orchidectomized Rat Brains |
| Q52532967 | [Treatment of Alzheimer' disease: critical evaluation of the use of anticholinesterase] |
Search more.